CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.99%174.950.4%$344.99m
AMRNAmarin Corporation Plc Sponsored ADR
-3.78%16.062.0%$149.53m
JAZZJazz Pharmaceuticals Plc
-1.08%140.562.2%$114.91m
PRGOPerrigo Co. Plc
-2.58%57.006.8%$67.38m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.10%119.536.3%$53.66m
MNKMallinckrodt Plc
-7.64%19.2321.1%$53.07m
ICLRICON Plc
-1.99%133.504.1%$46.79m
UTHRUnited Therapeutics Corporation
-2.05%107.8914.4%$42.00m
ICPTIntercept Pharmaceuticals, Inc.
-0.07%108.0118.6%$39.25m
SAGESAGE Therapeutics, Inc.
1.36%101.999.6%$36.88m
HZNPHorizon Pharma plc
0.25%19.937.4%$35.80m
ENDPEndo International Plc
-8.53%10.198.9%$33.99m
CTLTCatalent Inc
-3.91%34.642.4%$30.89m
MDCOMedicines Company
-3.54%19.0621.8%$26.60m
ZGNXZogenix, Inc.
-1.03%41.449.9%$24.77m

Company Profile

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.